Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Thalmann

Showing results (221-230 of 307) with videos related to

Pageof 31
Sort By:
BJU International|August 7, 2023
Oncological outcomes after attempted nerve-sparing radical prostatectomy (NSRP) in patients with high-risk prostate cancer are comparable to standard non-NSRP: a longitudinal long-term propensity-matched single-centre studyMarc A Furrer, Niranjan Sathianathen, Brigitta Gahl, et al.
BJU International|August 21, 2021
A longitudinal study evaluating interim assessment of neoadjuvant chemotherapy for bladder cancerMarc A Furrer, Nathan Papa, Sandro Luetolf, et al.
Cancer Research|September 6, 2005
Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivoGabri van der Pluijm, Ivo Que, Bianca Sijmons, et al.
The American Journal of Pathology|March 14, 2002
Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual diseaseAntoinette Wetterwald, Gabri van der Pluijm, Ivo Que, et al.
Cancer Research|May 15, 1994
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancerG N Thalmann, P E Anezinis, S M Chang, et al.
Cancers|December 18, 2020
Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma SignaturesSofia Karkampouna, Maria R De Filippo, Charlotte K Y Ng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
Immediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: results of the randomized trial SAKK 08/88Urs E Studer, Dieter Hauri, Silvia Hanselmann, et al.
BMC Cancer|June 27, 2019
miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivoMirjam Kiener, Lanpeng Chen, Markus Krebs, et al.
European Urology|March 12, 2014
Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic reviewGuillaume Ploussard, Siamak Daneshmand, Jason A Efstathiou, et al.
The Journal of Urology|February 3, 2021
Seminal Vesical Sparing Cystectomy for Bladder Cancer is Feasible with Good Functional Results without Impairing Oncological Outcomes: A Longitudinal Long-Term Propensity-Matched Single Center StudyMarc A Furrer, Bernhard Kiss, Urs E Studer, et al.
Pageof 31

Showing results (221-230 of 307) with videos related to

Sort By:
Pageof 31
BJU International|August 7, 2023
Oncological outcomes after attempted nerve-sparing radical prostatectomy (NSRP) in patients with high-risk prostate cancer are comparable to standard non-NSRP: a longitudinal long-term propensity-matched single-centre studyMarc A Furrer, Niranjan Sathianathen, Brigitta Gahl, et al.
BJU International|August 21, 2021
A longitudinal study evaluating interim assessment of neoadjuvant chemotherapy for bladder cancerMarc A Furrer, Nathan Papa, Sandro Luetolf, et al.
Cancer Research|September 6, 2005
Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivoGabri van der Pluijm, Ivo Que, Bianca Sijmons, et al.
The American Journal of Pathology|March 14, 2002
Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual diseaseAntoinette Wetterwald, Gabri van der Pluijm, Ivo Que, et al.
Cancer Research|May 15, 1994
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancerG N Thalmann, P E Anezinis, S M Chang, et al.
Cancers|December 18, 2020
Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma SignaturesSofia Karkampouna, Maria R De Filippo, Charlotte K Y Ng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
Immediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: results of the randomized trial SAKK 08/88Urs E Studer, Dieter Hauri, Silvia Hanselmann, et al.
BMC Cancer|June 27, 2019
miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivoMirjam Kiener, Lanpeng Chen, Markus Krebs, et al.
European Urology|March 12, 2014
Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic reviewGuillaume Ploussard, Siamak Daneshmand, Jason A Efstathiou, et al.
The Journal of Urology|February 3, 2021
Seminal Vesical Sparing Cystectomy for Bladder Cancer is Feasible with Good Functional Results without Impairing Oncological Outcomes: A Longitudinal Long-Term Propensity-Matched Single Center StudyMarc A Furrer, Bernhard Kiss, Urs E Studer, et al.
Pageof 31